Byetta was the first incretin mimetic drug to be approved for treating type 2 diabetes.
- Trade name: Byetta
- Generic name: Exenatide
- Drug class: GLP-1 receptor agonist (incretin mimetics)
- Manufacturer: AstraZeneca
How does Byetta work?
Byetta works by increasing the secretion of insulin from the pancreas, reducing the action of glucagon (the hormone which raises blood sugar levels) and slowing the absorption of glucose from the gut.
Together, these actions lower blood sugar levels and serve to reduce appetite.
Byetta, as do the other incretin mimetic drugs, have an advantage over a number of other diabetes drugs in that it helps people achieve weight loss.
Who is Byetta (exenatide) prescribed to?
Exenatide is typically prescribed with other drugs, and is used to reduce blood glucose levels amongst patients with type 2 diabetes who cannot achieve stable blood glucose by taking metformin, or metformin in combination with other drugs.
Exenatide is not prescribed on the NHS to patients with type 1 diabetes
How to take Byetta (exenatide)?
Byetta is taken by subcutaneous injection twice per day, usually an hour before breakfast and dinner.
Doses are typically injected into the thigh, abdomen or upper arm.
What are the side effects of Byetta (Exenatide)?
Byetta side effects include:
- Nervousness and
- Stomach pain
Exenatide can also lead to lower appetite, acid reflux and sweating.
Is Exenatide naturally occurring?
Exenatide is a man-made hormone that mimics the action of the naturally occurring hormone GLP-1.
Patients treated with Exenatide have been proven to achieve lower blood glucose levels.